Bennett Watson | ICR Westwicke, Investor Relations |
Dan Barber | Chief Executive Officer |
Ernie Toth | Chief Financial Officer |
Dr. Steve Wargacki | VP of R&D |
Ken Marshall | Chief Commercial Officer. |
Evan Hua | BMO Securities |
Jason Butler | JMP Securities |
Thomas Flaten | Lake Street Capital |
Andreas Argyrides | Wedbush |
Ram Selvaraju | H.C. Wainwright |
James Molloy | Alliance Global |
Good morning, and welcome to the Aquestive Therapeutics Second Quarter 2022 Conference Call. [Operator Instructions] As a reminder, this call will be recorded. I would now like to introduce your host for today’s conference call, Bennett Watson of ICR Westwicke, Investor Relations.
You may begin.
Thank you, operator.